diabetes

All-in-One Device Reduces the Number of Steps Needed for Diabetes Care
All-in-One Device Reduces the Number of Steps Needed for Diabetes Care
Brighter
devices
diabetes
Actiste
blood glucose monitoring
Flag link:
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Flag link:
Why Diabetes Stock Insulet Dropped 12% in October
Why Diabetes Stock Insulet Dropped 12% in October
Motley Fool
diabetes
devcies
Insulet
Flag link:
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Novo Nordisk
diabetes
OG2023SC
Rybelsus
oral semaglutide
Flag link:
Sanofi axes cancer combo, early next-gen diabetes drug
Sanofi axes cancer combo, early next-gen diabetes drug
Fierce Biotech
Sanofi
R&D
diabetes
cancer
isatuximab
Libtayo
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Hancock and Sanofi launches new life insurance product for diabetes
Hancock and Sanofi launches new life insurance product for diabetes
Bizjournals
life insurance
insurance
diabetes
Sanofi
Hancock
Flag link:
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Fierce Pharma
Eli Lilly
diabetes
Enrique Conterno
Flag link:
Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law
Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law
RAPS.org
Nevada
drug pricing
diabetes
Flag link:
‘Smart’ Inhaler Can Make Insulin Delivery Quick and Painless
‘Smart’ Inhaler Can Make Insulin Delivery Quick and Painless
Xtalks
Aerami Therapeutics
insulin
smart inhalers
diabetes
Flag link:
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Bayer
Eli Lilly
Humalong
Humulin
diabetes
whistleblower lawsuits
Flag link:
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
Flag link:
Can Synthetic Biology Make Insulin Faster, Better and Cheaper?
Can Synthetic Biology Make Insulin Faster, Better and Cheaper?
Forbes
diabetes
insulin
drug pricing
Genentech
gene editing
Flag link:
Sigilon Therapeutics approaches the clinic
Sigilon Therapeutics approaches the clinic
EP Vantage
Sigilon
orphan drug
hemophilia A
Eli Lilly
diabetes
Flag link:
Novo and Sanofi make case for hypo-reducing insulins at EASD
Novo and Sanofi make case for hypo-reducing insulins at EASD
Pharmaforum
Novo Nordisk
Sanofi
EASD
diabetes
hypoglycemia
insulin
Lantus
Tresiba
Flag link:
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes
Flag link:
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
Fierce Pharma
Novo Nordisk
Ozempic
JNJ
Invokana
Victoza
diabetes
EASD
Flag link:
Factbox: Britain's insulin providers prepare for Brexit fallout
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Novo Nordisk
Eli Lilly
Sanofi
UK
Brexit
insulin
diabetes
Flag link:
AstraZeneca diabetes drug granted fast track status for heart failure treatment
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Flag link:

Pages